Vitamin D3 Binding Protein Required for in Vitro Activation of Macrophages After Alkylglycerol Treatment of Mouse Peritoneal Cells
Overview
Authors
Affiliations
In vitro treatment of peritoneal cells with dodecylglycerol (DDG) in 10% foetal calf serum (FCS) supplemented medium RPMI-1640 results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This macrophage activation process requires a serum factor in the alpha 2-globulin fraction. When mouse peritoneal cells were treated with 50 ng DDG/ml in a serum-free 0.1% egg albumin-supplemented medium RPMI-1640 (EA medium) for 30 min and cultured in EA medium containing electrophoretically fractionated alpha 2-globulin for 3 hr, a markedly enhanced activation of macrophages was observed. To improve fractionation of alpha 2-globulin, FCS was first precipitated with 50% saturated ammonium sulphate and then the supernatant electrophoretically fractionated. The resultant alpha 2-globulin fraction was unable to support activation of macrophages. Vitamin D3 binding protein (DBP) of the alpha 2-globulin fraction is known to be precipitable by 50% saturated ammonium sulphate. When human alpha 2-globulin was treated with antiserum against human DBP and used in a medium for cultivation of DDG-treated peritoneal cells, no significant activation of macrophages was observed. Cultivation of DDG-treated peritoneal cells in a medium containing a low concentration of purified human DBP (group specific component, Gc) produced a greatly enhanced ingestion activity of macrophages. Purified human Gc protein, when used in an EA medium for step-wise cultivation of DDG-treated B and untreated T cells, was efficiently converted to a macrophage-activating factor.
Kirikovich S, Levites E, Proskurina A, Ritter G, Dolgova E, Ruzanova V Curr Issues Mol Biol. 2024; 46(10):10934-10959.
PMID: 39451530 PMC: 11506609. DOI: 10.3390/cimb46100650.
Mondal G, Saroha A, Bose P, Chatterjee B Glycoconj J. 2016; 33(2):209-18.
PMID: 27034286 DOI: 10.1007/s10719-016-9658-2.
An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia.
Ahmad Y, Sharma N, Garg I, Ahmad M, Sharma M, Bhargava K PLoS One. 2013; 8(7):e67548.
PMID: 23844025 PMC: 3699623. DOI: 10.1371/journal.pone.0067548.
Toyohara Y, Hashitani S, Kishimoto H, Noguchi K, Yamamoto N, Urade M Oncol Lett. 2012; 2(4):685-691.
PMID: 22848250 PMC: 3406437. DOI: 10.3892/ol.2011.306.
An update on the therapeutic role of alkylglycerols.
Iannitti T, Palmieri B Mar Drugs. 2010; 8(8):2267-300.
PMID: 20948908 PMC: 2953404. DOI: 10.3390/md8082267.